Code | Display | Definition |
NACHC.A0.DE1 |
Encounter Type |
Encounter Type |
NACHC.A1.DE1 |
HIV Diagnosis |
HIV Diagnosis |
NACHC.A2.DE1 |
HIV Test |
HIV Test |
NACHC.A2.DE216 |
HIV Test Ordered |
HIV Test Ordered |
NACHC.B1.DE1 |
Hepatitis C Diagnosis |
Hepatitis C Diagnosis |
NACHC.B2.DE1 |
Hepatitis C Test |
Hepatitis C Test |
NACHC.B2.DE103 |
Antinuclear antibodies (ANA) |
Hepatitis C Test - Antinuclear antibodies (ANA) |
NACHC.B2.DE104 |
Hepatitis C antibody |
Hepatitis C Test - Hepatitis C antibody |
NACHC.B2.DE105 |
Hepatitis C antibody; confirmatory test (eg, immunoblot) |
Hepatitis C Test - Hepatitis C antibody; confirmatory test (eg, immunoblot) |
NACHC.B2.DE106 |
Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, direct probe technique |
Hepatitis C Test - Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, direct probe technique |
NACHC.B2.DE107 |
Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, amplified probe technique, includes reverse transcription when performed |
Hepatitis C Test - Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, amplified probe technique, includes reverse transcription when performed |
NACHC.B2.DE108 |
Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, quantification, includes reverse transcription when performed |
Hepatitis C Test - Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, quantification, includes reverse transcription when performed |
NACHC.B2.DE109 |
Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis C virus |
Hepatitis C Test - Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis C virus |
NACHC.B2.DE112 |
Hepatitis C Procedures |
Hepatitis C Procedures |
NACHC.B2.DE113 |
RNA testing for Hepatitis C documented as performed within 6 months prior to initiation of antiviral treatment for Hepatitis C (HEP-C) |
Hepatitis C Procedures - RNA testing for Hepatitis C documented as performed within 6 months prior to initiation of antiviral treatment for Hepatitis C (HEP-C) |
NACHC.B2.DE114 |
Hepatitis C quantitative RNA testing documented as performed at 12 weeks from initiation of antiviral treatment (HEP-C) |
Hepatitis C Procedures - Hepatitis C quantitative RNA testing documented as performed at 12 weeks from initiation of antiviral treatment (HEP-C) |
NACHC.B2.DE115 |
Ribonucleic acid (RNA) testing for Hepatitis C viremia ordered or results documented (HEP C) |
Hepatitis C Procedures - Ribonucleic acid (RNA) testing for Hepatitis C viremia ordered or results documented (HEP C) |
NACHC.B2.DE116 |
Hepatitis C genotype testing documented as performed prior to initiation of antiviral treatment for Hepatitis C (HEP C) |
Hepatitis C Procedures - Hepatitis C genotype testing documented as performed prior to initiation of antiviral treatment for Hepatitis C (HEP C) |
NACHC.B2.DE117 |
Hepatitis C screening documented as performed (HIV) |
Hepatitis C Procedures - Hepatitis C screening documented as performed (HIV) |
NACHC.B2.DE118 |
Patient receiving antiviral treatment for Hepatitis C (HEP-C) |
Hepatitis C Procedures - Patient receiving antiviral treatment for Hepatitis C (HEP-C) |
NACHC.B2.DE119 |
Collection of venous blood by venipuncture |
Hepatitis C Procedures - Collection of venous blood by venipuncture |
NACHC.B2.DE120 |
Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver |
Hepatitis C Procedures - Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver |
NACHC.C1.DE1 |
Syphilis Diagnosis |
Syphilis Diagnosis |
NACHC.C2.DE1 |
Syphilis Test |
Syphilis Test |
NACHC.D1.DE1 |
Gonorrhea Diagnosis |
Gonorrhea Diagnosis |
NACHC.D2.DE1 |
Gonorrhea Test |
Gonorrhea Test |
NACHC.E1.DE1 |
Chlamydia Diagnosis |
Chlamydia Diagnosis |
NACHC.E2.DE1 |
Chlamydia Test |
Chlamydia Test |
NACHC.F1.DE1 |
Drug Rehabilitation |
Drug Rehabilitation |
NACHC.F1.DE12 |
Injection Findings |
Injection Findings |
NACHC.F1.DE15 |
Injection Drug Use Diagnosis |
Injection Drug Use Diagnosis |
NACHC.F1.DE200 |
Injection Drug Use |
Injection Drug Use |
NACHC.F2.DE1 |
Pregnancy Encounters |
Pregnancy Encounters |
NACHC.F2.DE38 |
Third Trimester Encounters |
Third Trimester Encounters |
NACHC.F2.DE42 |
Pregnancy Supervision |
Pregnancy Supervision |
NACHC.F2.DE108 |
Maternal Care |
Maternal Care |
NACHC.F2.DE672 |
Pregnancy Procedures |
Pregnancy Procedures |
NACHC.F2.DE904 |
Pregnancy Observations |
Pregnancy Observations |
NACHC.F2.DE1131 |
Pregnancy Conditions |
Pregnancy Conditions |
NACHC.G1.DE1 |
Post Exposure Prophylaxis |
Post Exposure Prophylaxis |
NACHC.G1.DE5 |
PEP Medication Prescriptions |
PEP Medication Prescriptions |
NACHC.G1.DE143 |
PEP Dispensed Medications |
PEP Dispensed Medications |
NACHC.G2.DE1 |
Prep Medication Prescriptions |
Prep Medication Prescriptions |
NACHC.G2.DE26 |
Prep Dispensed Medications |
Prep Dispensed Medications |
NACHC.H1.DE1 |
Previous HIV Screening |
Previous HIV Screening |
NACHC.H1.DE2 |
Previous HIV Diagnosis |
Previous HIV Diagnosis |
NACHC.H1.DE3 |
Patient Currently Pregnant |
Patient Currently Pregnant |
NACHC.H1.DE4 |
Patient Diagnosed with HCV |
Patient Diagnosed with HCV |
NACHC.H1.DE5 |
Patient Diagnosed with Syphilis |
Patient Diagnosed with Syphilis |
NACHC.H1.DE6 |
Patient Diagnosed with Gonorrhea |
Patient Diagnosed with Gonorrhea |
NACHC.H1.DE7 |
Patient Diagnosed with Chlamydia |
Patient Diagnosed with Chlamydia |
NACHC.H1.DE8 |
Patient has used Injection Drugs |
Patient has used Injection Drugs |
NACHC.H1.DE9 |
Seeking STD Treatment |
Seeking STD Treatment |
NACHC.H1.DE10 |
Previous experience with PREP |
Previous experience with PREP |
NACHC.H1.DE11 |
Sexual Activity - Past Year |
Sexual Activity - Past Year |
NACHC.H1.DE12 |
Sexual Activity - History |
Sexual Activity - History |
NACHC.H1.DE13 |
Sexual Activity - Men |
Sexual Activity - Men |
NACHC.H1.DE14 |
Sexual Activity - Women |
Sexual Activity - Women |
NACHC.H1.DE15 |
Sexual Activity - Number of Partners |
Sexual Activity - Number of Partners |
NACHC.H1.DE16 |
Sexual Activity - New Partner Past 3 Months |
Sexual Activity - New Partner Past 3 Months |
NACHC.H1.DE17 |
Sexual Activity - Partners History |
Sexual Activity - Partners History |
NACHC.H1.DE18 |
Sexual Activity - Partners Number of Partners |
Sexual Activity - Partners Number of Partners |
NACHC.H1.DE19 |
Sexual Activity - Partners HIV History |
Sexual Activity - Partners HIV History |
NACHC.H1.DE20 |
Sexual Activity - Drug or Alcohol Use |
Sexual Activity - Drug or Alcohol Use |
NACHC.H1.DE21 |
Sexual Activity - Exchanged for Sex |
Sexual Activity - Exchanged for Sex |
NACHC.H1.DE22 |
Sexual Activity - Coercion |
Sexual Activity - Coercion |
NACHC.H1.DE23 |
Sexual Activity - Kind of Sex - Anal |
Sexual Activity - Kind of Sex - Anal |
NACHC.H1.DE24 |
Sexual Activity - Male - Kind of Sex - Receptive Anal |
Sexual Activity - Male - Kind of Sex - Receptive Anal |
NACHC.H1.DE25 |
Sexual Activity - Male - Kind of Sex - Insertive Anal |
Sexual Activity - Male - Kind of Sex - Insertive Anal |
NACHC.H1.DE26 |
Sexual Activity - Kind of Sex - Vaginal |
Sexual Activity - Kind of Sex - Vaginal |